Neuronal and Axonal Loss in Normal-Appearing Gray Matter and Subpial Lesions in Multiple Sclerosis

Journal of Neuropathology and Experimental Neurology

Volumn 74, Issue 5, 2015, Pages 453-458

  Klaver, Roel ^a   Popescu, Veronica ^a   Voorn, Pieter ^a   Galis De Graaf, Yvonne ^a   Van Der Valk, Paul ^a   De Vries, Helga E ^a   Schenk, Geert J ^a   Geurts, Jeroen J G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Axonal loss; Gray matter pathology; Multiple sclerosis; Neurodegeneration; Neuronal loss; Subpial lesions

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; MYELIN PROTEIN; NEURON SPECIFIC NUCLEAR PROTEIN; PROTEOLIPID PROTEIN; SMI312 ANTIBODY; SMI312 PROTEIN; UNCLASSIFIED DRUG; NERVE PROTEIN;

ADULT; AGED; ARTICLE; AUTOPSY; AXON DENSITY; BRAIN CORTEX; BRAIN CORTEX LESION; BRAIN NERVE CELL; CELL DENSITY; CENTRAL NERVOUS SYSTEM DISEASE; CINGULATE GYRUS; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATION; FEMALE; GRAY MATTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELINATION; NERVE FIBER; NERVOUS SYSTEM PARAMETERS; NEURON DENSITY; NEUROPATHOLOGY; PRIORITY JOURNAL; VERY ELDERLY; CELL COUNT; COMPLICATION; FRONTAL LOBE; METABOLISM; NERVE CELL; NEURODEGENERATIVE DISEASES; NONPARAMETRIC TEST; PATHOLOGY;

AGED; AGED, 80 AND OVER; AXONS; CELL COUNT; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; STATISTICS, NONPARAMETRIC;

EID: 84931072824     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000189     Document Type: Article

References (30)

1. Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol 2008;7:841-51
2. Amato MP, Bartolozzi ML, Zipoli V, et al. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 2004;63:89-93
3. Amato MP, Portaccio E, Goretti B, et al. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol 2007;64:1157-61
4. Calabrese M, Agosta F, Rinaldi F, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009;66:1144-50
5. BL L, Vedeler CA, Nyland HI, Trapp BD, MLrk SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003;62:723-32
6. Klaver R, De Vries HE, Schenk GJ, Geurts JJ. Grey matter damage in multiple sclerosis: A pathology perspective. Prion 2013;7:66-75
7. Vercellino M, Masera S, Lorenzatti M, et al. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009;68:489-502
8. Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005;64:1101-7
9. Gilmore CP, Donaldson I, Bö L, Owens T, Lowe J, Evangelou N. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: A comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 2009;80:182-87
10. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128:2705-12
11. Kutzelnigg A, Faber-Rod JC, Bauer J, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007;17:38-44
12. Howell OW, Reeves CA, Nicholas R, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 2011;134:2755-71
13. Kooi EJ, Geurts JJ, van Horssen J, BL L, van der Valk P. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis. J Neuropathol Exp Neurol 2009;68:1021-28
14. Seewann A, Kooi EJ, Roosendaal SD, et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012;78:302-8
15. BL L, Vedeler CA, Nyland H, Trapp BD, MLrk SJ. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003;9:323-31
16. Peterson JW, Bö L, Mörk S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389-400
17. Wegner C, Esiri MM, Chance SA, Palace J, Mathews PM. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006; 67:960-67
18. Magliozzi R, Howell OW, Reeves C, et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010;68:477-93
19. Seewann A, Kooi EJ, Roosendaal SD, Barkhof F, van der Valk P, Geurts JJ. Translating pathology in multiple sclerosis: The combination of postmortem imaging, histopathology and clinical findings. Acta Neurol Scand 2009;119:349-55
20. Popescu V, Klaver R, Voorn P, et al. What drives MRIVmeasured cortical atrophy in multiple sclerosis Mult Scler 2015. doi: 10. 1177/1352458514562440. [Epub ahead of print].
21. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 1946;94:239-47
22. Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52:650-53
23. Giehl KM, Tetzlaff W. BDNF and NT-3, but not NGF, prevent axotomyinduced death of rat corticospinal neurons in vivo. Eur J Neurosci 1996; 8:1167-75
24. Bonatz H, Röhrig S, Mestres P, Meyer M, Giehl KM. An axotomy model for the induction of death of rat and mouse corticospinal neurons in vivo. J Neurosci Methods 2000;100:105-15
25. Witte ME, Mahad DJ, Lassmann H, van Horssen J. Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis. Trends Mol Med 2014;20:179-87
26. Pitt D, Werner P, Raine CS. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 2000;6:67-70
27. Haider L, Simeonidou C, Steinberger G, et al. Multiple sclerosis deep grey matter: The relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry 2014;85:1386-95
28. Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 2009;8:280-91
29. Antulov R, Weinstock-Guttman B, Cox JL, et al. Gender-related differences in MS: A study of conventional and nonconventional MRI measures. Mult Scler 2009;15:345-54
30. Schoonheim MM, Popescu V, Rueda Lopes FC, et al. Subcortical atrophy and cognition: Sex effects in multiple sclerosis. Neurology 2012;79: 1754-61